• Explore /
  • Poster
  • / Tumor responses and early onset cytokine release syndrome in synovial sarcoma patients treated with a novel affinity-enhanced NY-ESO-1-targeting TCR-redirected T cell transfer.

Tumor responses and early onset cytokine release syndrome in synovial sarcoma patients treated with a novel affinity-enhanced NY-ESO-1-targeting TCR-redirected T cell transfer.

Abstract Poster

Authors

null

Mikiya Ishihara

Mie University, Tsu, Japan

Mikiya Ishihara , Shigehisa Kitano , Hiroyoshi Hattori , Yoshihiro Miyahara , Hidefumi Kato , Hideyuki Mishima , Noboru Yamamoto , Takeru Funakoshi , Takashi Kojima , Tetsuro Sasada , Eiichi Sato , Sachiko Okamoto , Daisuke Tomura , Hideto Chono , Ikuei Nukaya , Junichi Mineno , Hiroaki Ikeda , Takashi Watanabe , Shinichi Kageyama , Hiroshi Shiku

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2019 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Developmental Immunotherapy and Tumor Immunobiology

Track

Developmental Therapeutics—Immunotherapy

Sub Track

Cellular Immmunotherapy

Clinical Trial Registration Number

NCT02366546

Citation

J Clin Oncol 37, 2019 (suppl; abstr 2530)

DOI

10.1200/JCO.2019.37.15_suppl.2530

Abstract #

2530

Poster Bd #

174

Abstract Disclosures

Similar Posters

First Author: Marcus O. Butler

First Author: Akira Kawai

Poster

2024 ASCO Annual Meeting

<span>Phase IIA study of high-affinity TCR-T (TAEST16001) targeting NY-ESO-1 in soft tissue sarcoma.</span>

Phase IIA study of high-affinity TCR-T (TAEST16001) targeting NY-ESO-1 in soft tissue sarcoma.

First Author: Jiayong Liu

First Author: Dejka M. Araujo